XRP Bearish Triangle Holds Back Bulls, Toncoin (TON) Records Pivotal Breakout, Bitcoin (BTC) Surpasses $60,000: What's Next? By U.Today
U.Today – has been moving in a symmetrical triangle, a pattern that tends to go up or down depending on…
Business
Unlock the secrets of business, stocks, crypto, banks, insurance, and automobiles with our informative blog. Expert insights and tips await you.
Oil prices fall to $58,000 as weekend rally cools; Fed in focus By Investing.com
Investing.com — Bitcoin price fell on Monday, reversing course after a brief rally over the weekend, with attention focused on…
Web5 and AI-LLM architecture by Chainwire
Singapore, Singapore, September 16, 2024, Chainwire MEET48 is poised to revolutionize the Web3 entertainment landscape through a series of innovative…
A mystery of $100 million in bitcoins surprises a major exchange in 24 hours By U.Today
U.Today – Although Saturday and Sunday are traditionally days of rest for traditional financial markets, the world of cryptocurrencies never…
This is the amount of bitcoins owned by Elon Musk's innovative and leading company, according to U.Today
U.Today – According to data shared by Arkham Intelligence, the space rocket company created and run by tech billionaire Elon…
Dormant Bitcoin Wallets Wake Up as BTC Price Soars to $60,000 By U.Today
U.Today – the largest cryptocurrency by market value – surpassed $60,000 and hit a high of $60,660 in trading on…
Veteran Trader Peter Brandt Predicts Major Change in Trend Between Bitcoin and Gold By U.Today
U.Today – Veteran trader Peter Brandt has recently shared his thoughts on the Bitcoin/Gold ratio, implying that a tradable local…
Erik Voorhees makes important comment on MicroStrategy's latest Bitcoin purchase by U.Today
U.Today – Erik Voorhees, an OG who founded Spaceshift and recently also Venice AI, has published a post on the…
DirecTV and Disney reach deal to end blackout in time for college football
DirecTV and Disney have reached an agreement that allows Disney's ESPN and other channels to once again be available to…
Pfizer's drug for cancer cachexia shows positive results in mid-phase trials
PfizerPfizer's experimental drug for a common, potentially fatal disease that causes cancer patients to lose appetite and weight showed positive…